Omadacycline: An Oral Antibiotic for the Treatment of Bacterial Skin Infections and Pneumonia in an Era of Unmet Clinical Need | MDedge

Article Type

Changed

Tue, 06/14/2022 - 12:55

Despite advances in the management of skin and soft tissue infections and community-acquired pneumonia, challenges persist. This 2-part supplement to The Journal of Family Practice summarizes the findings of 3 phase 3 studies of omadacycline.

Read More

Issue

The Journal of Family Practice - 71(5)

Publications

MDedge Family Medicine

The Journal of Family Practice

Sections

Despite advances in the management of skin and soft tissue infections and community-acquired pneumonia, challenges persist. This 2-part supplement to The Journal of Family Practice summarizes the findings of 3 phase 3 studies of omadacycline.

Read More

Despite advances in the management of skin and soft tissue infections and community-acquired pneumonia, challenges persist. This 2-part supplement to The Journal of Family Practice summarizes the findings of 3 phase 3 studies of omadacycline.

Read More

Issue

The Journal of Family Practice - 71(5)

Issue

The Journal of Family Practice - 71(5)

Publications

MDedge Family Medicine

The Journal of Family Practice

Publications

MDedge Family Medicine

The Journal of Family Practice

Article Type

Sections

Disallow All Ads

Content Gating

No Gating (article Unlocked/Free)

Alternative CME

Disqus Comments

Default

Eyebrow Default

Information from Industry - Sponsored Supplement

Gate On Date

Thu, 05/12/2022 - 11:00

Un-Gate On Date

Thu, 05/12/2022 - 11:00

Consolidated Pubs: Do Not Show Source Publication Logo

Use ProPublica

CFC Schedule Remove Status

Thu, 05/12/2022 - 11:00

Conference Recap Checkbox

Not Conference Recap

Clinical Edge

Display the Slideshow in this Article

Medscape Article

Display survey writer

Reuters content

Disable Inline Native ads

WebMD Article